Saenger Bradley Insider Trades

Insider Trading History

Track insider trading activity for Saenger Bradley. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Financial Officer
Holding Value $463k 39,012 shares
Last Trade
Feb 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$557k 39,012 shares
$14.29
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Financial Officer
Holding Value $463k 39,011 shares
Last Trade
Feb 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$557k 39,011 shares
$14.29
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Financial Officer
Holding Value $306k 25,792 shares
Last Trade
Feb 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$208k 25,792 shares
$8.05
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Financial Officer
Holding Value $3.35M 282,000 shares
Last Trade
Feb 27, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$332M 282,000 shares
$1,177.60
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Financial Officer
Holding Value $2.38M 200,000 shares
Last Trade
Feb 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.92B 200,000 shares
$14,622.02
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Financial Officer
Holding Value $2.38M 200,000 shares
Last Trade
Feb 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.92B 200,000 shares
$14,622.02
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Financial Officer
Holding Value $10.7M 900,000 shares
Last Trade
Feb 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$119B 900,000 shares
$132,352.00
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Financial Officer
Holding Value $10.7M 900,000 shares
Last Trade
Feb 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$119B 900,000 shares
$132,352.00
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Financial Officer
Holding Value $10.7M 900,000 shares
Last Trade
Feb 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$119B 900,000 shares
$132,352.00
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Financial Officer
Holding Value $10.7M 900,000 shares
Last Trade
Feb 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$119B 900,000 shares
$132,352.00
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Financial Officer
Holding Value $6.42M 540,000 shares
Last Trade
Feb 23, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$422B 540,000 shares
$780,800.00
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Financial Officer
Holding Value $6.42M 540,000 shares
Last Trade
Feb 23, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$422B 540,000 shares
$780,800.00
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Financial Officer
Holding Value $4.28M 360,000 shares
Last Trade
May 04, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$177B 360,000 shares
$492,800.00
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Financial Officer
Holding Value $4.28M 360,000 shares
Last Trade
May 04, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$177B 360,000 shares
$492,800.00
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Financial Officer
Holding Value $285k 24,000 shares
Last Trade
Feb 25, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.21B 24,000 shares
$258,816.00
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Financial Officer
Holding Value $285k 24,000 shares
Last Trade
Feb 25, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.21B 24,000 shares
$258,816.00
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Financial Officer
Holding Value $343k 28,835 shares
Last Trade
May 06, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$378B 28,835 shares
$13,120,000.00
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Financial Officer
Holding Value $343k 28,835 shares
Last Trade
May 06, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$378B 28,835 shares
$13,120,000.00
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Financial Officer
Holding Value $61.4k 5,170 shares
Last Trade
Feb 26, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$62.5B 5,170 shares
$12,096,000.00
$11.88
Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding TNXP
Chief Financial Officer
Holding Value $61.4k 5,170 shares
Last Trade
Feb 26, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$62.5B 5,170 shares
$12,096,000.00
$11.88

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up